Cellectis Valor Contábil/Ação
Qual é o Valor Contábil/Ação de Cellectis?
O Valor Contábil/Ação de Cellectis é 4.36
Qual é a definição de Valor Contábil/Ação?
O valor contábil por ação é um ativo da empresa menos as responsabilidades dividido pelo número de ações em circulação.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor Contábil/Ação de empresas na Setor Health Care em NASDAQ em comparação com Cellectis
O que Cellectis faz?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Empresas com valor contábil/ação semelhantes a Cellectis
- Morses Club PLC tem Valor Contábil/Ação de 4.35
- Nokian Renkaat Oyj tem Valor Contábil/Ação de 4.36
- Tandy Leather Factory tem Valor Contábil/Ação de 4.36
- Metalla Royalty & Streaming tem Valor Contábil/Ação de 4.36
- Las Vegas Sands Corp tem Valor Contábil/Ação de 4.36
- WPP Plc tem Valor Contábil/Ação de 4.36
- Cellectis tem Valor Contábil/Ação de 4.36
- Jacques Bogart SA tem Valor Contábil/Ação de 4.36
- Bowl America tem Valor Contábil/Ação de 4.36
- Insignia Systems tem Valor Contábil/Ação de 4.36
- Crown Crafts tem Valor Contábil/Ação de 4.36
- Co-Diagnostics tem Valor Contábil/Ação de 4.37
- ASE Technology Co.Ltd tem Valor Contábil/Ação de 4.37